CN103356765B - Comprehensive breast beauty medicament and preparation method thereof - Google Patents
Comprehensive breast beauty medicament and preparation method thereof Download PDFInfo
- Publication number
- CN103356765B CN103356765B CN201310232737.1A CN201310232737A CN103356765B CN 103356765 B CN103356765 B CN 103356765B CN 201310232737 A CN201310232737 A CN 201310232737A CN 103356765 B CN103356765 B CN 103356765B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- granule
- breast
- stir
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
The invention relates to a comprehensive breast beauty medicament and a preparation method thereof. The breast beauty medicament is prepared from astragalus membranaceus, red ginseng, elecampane, Chinese-date, ricepaper pith, seed of cowherb, manis pentadactyla, radix bupleuri, radix paeoniae alba, white atractylodes rhizome, angelica sinensis and liquorice according to specific ratio; and the materials are prepared into medicinal granules by the steps of high-temperature leaching, filtering, heating, concentrating, soft material preparation, granulating and drying, screening, packaging and the like. The medicament has a combined action of tonifying qi-blood and soothing the liver to resolve depression after being taken, facilitates secondary hyperplasia development of a mammary gland cell, and also can keep the elasticity of the breasts after delactation. Thus, the inaesthetic problems such as flat breasts, mammary gland prolapse, mammary gland deflection and mastatrophia of postpartum woman are corrected. The lying-in woman who takes the medicament still can keep breast uplift after a plurality of years; and the medicament is safe and reliable to a human body.
Description
Technical field
The present invention relates to the medicinal preparation field of animals and plants material, particularly U.S. newborn medicine of one and preparation method thereof.
Background technology
Female breast is suckling organ, very important to the existence of baby, g and D.But suckling is not unique function of breast.Another critical function of breast is the necessary requirement of the important secondary sex characteristics of women and feminine charm.Healthy, plentiful breast can bring confidence and happiness to women usually.
As time goes on breast can change.Therefore, the women of all ages and classes, faced by breast problem also different, for puerpera, the experience of son is produced in childbirth, often has influence on the health of breast and attractive in appearance.
Concrete reason is: puerpera often occurs the symptom on some healths in puerperal, for the puerpera that some bodies are thin, because postpartum hemorrhage is too much, cause puerpera's QI and blood deficiency, be embodied in degradation symptom under weak, pale complexion, hyperhidrosis, appetite, after this can cause puerpera to produce, the distortion of breast, as mammary gland is flat, mammary gland is sagging, mammary gland is crooked, mammary gland atrophys etc., for the puerpera of QI and blood deficiency, need to adopt qi and blood tonifying method to nurse one's health, can play and recover mammary gland elasticity, the effect of strong breast.
In addition for the partially fat puerpera of some bodily forms, there is stagnation of QI due to depression of the liver symptom puerperal, lose blood puerperal less although be embodied in, have rosy cheeks, but appetite extreme difference, with dyspepsia, depressed emotion, functional activity of QI being not smooth, this can affect the attractive in appearance of breast equally, for the puerpera of this class stagnation of QI due to depression of the liver, need to adopt the conditioning of dispersing the stagnated live-QI to relieve the stagnation of QI method, reach the effect of mamaplasty equally.
For other puerperas, then there will be the summary symptom of QI and blood deficiency and stagnation of QI due to depression of the liver, cause the problems such as postpartum mammary gland is flat, and mammary gland is sagging, and mammary gland is crooked, mammary gland atrophy.One of them reason is: puerperal QI and blood deficiency, cause puerpera's inappetence, depressed, melancholy for a long time, finally result in functional activity of QI being not smooth, stagnation of QI due to depression of the liver.At this time, solely adopt qi and blood tonifying method, or dispersing the stagnated live-QI to relieve the stagnation of QI method is nursed one's health to puerpera, does not have very good effect.
Summary of the invention
Technical problem to be solved by this invention is: puerpera produces rear appearance, the symptomes complice of QI and blood deficiency and stagnation of QI due to depression of the liver, has influence on the recovery of puerperal breasts, and solely adopts qi and blood tonifying method, or dispersing the stagnated live-QI to relieve the stagnation of QI method is nursed one's health puerpera, do not have very good effect.
For solving this technical problem: the technical solution used in the present invention is:
The invention provides a kind of comprehensive breast beauty medicament, this medicine contributes to, the symptomes complice of the QI and blood deficiency that conditioning puerpera causes puerperal and stagnation of QI due to depression of the liver, and play the effect of the good strong breast of U.S.'s breast, the composition of medicine, counts by weight
The Radix Astragali 38 ~ 42 parts, Radix Ginseng Rubra 19 ~ 21 parts, the Radix Aucklandiae 4.5 ~ 5.5 parts, 28.5 ~ 31.5 parts, Fructus Jujubae, Medulla Tetrapanacis 9.5 ~ 10.5 parts, Semen Vaccariae (stir-fry) 28.5 ~ 31.5 parts, Squama Manis (cannon) 14 ~ 16 parts, Radix Bupleuri 9.5 ~ 10.5 parts, the Radix Paeoniae Alba 19 ~ 21 parts, the Rhizoma Atractylodis Macrocephalae (stir-fry) 19 ~ 21 parts, Radix Angelicae Sinensis 19 ~ 21 parts and 9.5 ~ 10.5 parts, Radix Glycyrrhizae
As preferably: the composition of U.S. newborn medicine, count by weight: the Radix Astragali 40 parts, Radix Ginseng Rubra 20 parts, the Radix Aucklandiae 5 parts, 30 parts, Fructus Jujubae, Medulla Tetrapanacis 10 parts, Semen Vaccariae (stir-fry) 30 parts, Squama Manis (cannon) 15 parts, Radix Bupleuri 10 parts, the Radix Paeoniae Alba 20 parts, the Rhizoma Atractylodis Macrocephalae (stir-fry) 20 parts, Radix Angelicae Sinensis 20 parts and 10 parts, Radix Glycyrrhizae
Above-described raw material, all needs the measured Chinese medicine of matter, can not use succedaneum.
This U.S. newborn medicine is said solid preparation on pharmaceutics, specifically, is dissolved granule.
Present invention also offers a kind of preparation method of said medicine dissolved granule, specifically have the following steps
(1) preparation of raw material: take the raw material Radix Astragali, Radix Ginseng Rubra, the Radix Aucklandiae, Fructus Jujubae, Medulla Tetrapanacis, Semen Vaccariae (stir-fry), Squama Manis (cannon), Radix Bupleuri, the Radix Paeoniae Alba, the Rhizoma Atractylodis Macrocephalae (stir-fry), Radix Angelicae Sinensis and Radix Glycyrrhizae by weight, put into extractor to be uniformly mixed, add the water soaking 30 minutes of 5-20 times amount;
(2) high-temp extracting and filtration: the raw material prepared in heating decoction step (1) 2-3 hours, leaching decocting liquid, its slag adds the water of 5-10 times amount again, heating decoction 1.5-2 hours, leaching decocting liquid, add the water of 4-6 times amount again toward its slag, heating decoction 1-1.5 hours, merges these three gained filtrates after filtering;
(3) heating is concentrated: by the filtrate of last for step (2) gained, heating is concentrated into paste, makes moisture be down to 28-31%;
(4) make soft material: by the thick paste of step (3) gained, add the starch of 2.5-3.5 times of volumes, stir, and then add the ethanol that volume ratio accounts for 70-90%, stir into uniform soft material;
(5) granulating is dry: soft material step (4) obtained, and makes granule through 12 mesh sieves, then by gained granule in 60-90 DEG C of Uniform Ventilation dryings;
(6) granule is screened: by the granule of step (5) gained; through 12 mesh sieve screenings; after suitably pulverizing without the granule of sieve; again again through 12 mesh sieve screenings; after being gathered by granule under twice screening, then sieve the fine powder gone wherein with 40 mesh sieves, obtain finished product electuary granule; not by the granule of 12 mesh sieves and the production that be can be used for next batch by the dust of 40 mesh sieves, be used for regulating the humidity of soft material.
(7) pack: by quantitative electuary granule being packed of often wrapping.
When taking the newborn medicine instant of U.S. of the present invention, taboo and tobacco and wine, the mixed clothes of numb, peppery, raw, cold food;
When taking the newborn medicine instant of U.S. of the present invention, various Western medicine is taken in taboo;
During puerpera suffers from other diseases, forbid taking.
The invention has the beneficial effects as follows: the newborn medicine of U.S. of the present invention is safe and reliable, instructions of taking is simple, there is the comprehensive function of qi and blood tonifying and dispersing the stagnated live-QI to relieve the stagnation of QI, the mechanism of action of medicine is, by promoting that the second time hypertrophy of mammary glandular cell is grown, thus promotes that the growth of corpus mamma is grown, mammary gland is made to recover elasticity, add continual galactopoiesis, even if after ablactation, still keep mammary gland elasticity.Coordinate excellent medicated bra to hold up mammary gland again, substantially correct for the series of problems such as mammary gland is flat, mammary gland is sagging, mammary gland is crooked, mammary gland atrophy, contribute to the strong protuberance of mammary gland, keep mammary contour attractive in appearance.
Accompanying drawing explanation
Fig. 1 embodiment part, calculates in the process of " udder size ", concrete measuring position schematic diagram.
Detailed description of the invention
Embodiment 1:
In the present embodiment, the composition of U.S. newborn medicine, counts: the Radix Astragali 38 parts, Radix Ginseng Rubra 21 parts, the Radix Aucklandiae 4.5 parts, 28.5 parts, Fructus Jujubae, Medulla Tetrapanacis 10.5 parts, Semen Vaccariae (stir-fry) 31.5 parts, Squama Manis (cannon) 14 parts, Radix Bupleuri 10.5 parts, the Radix Paeoniae Alba 21 parts, the Rhizoma Atractylodis Macrocephalae (stir-fry) 21 parts, Radix Angelicae Sinensis 19 parts and 10.5 parts, Radix Glycyrrhizae by weight.
The preparation method of dissolved granule as used in the description.
Embodiment 2:
In the present embodiment, the composition of U.S. newborn medicine, counts: the Radix Astragali 40 parts, Radix Ginseng Rubra 20 parts, the Radix Aucklandiae 5 parts, 30 parts, Fructus Jujubae, Medulla Tetrapanacis 10 parts, Semen Vaccariae (stir-fry) 30 parts, Squama Manis (cannon) 15 parts, Radix Bupleuri 10 parts, the Radix Paeoniae Alba 20 parts, the Rhizoma Atractylodis Macrocephalae (stir-fry) 20 parts, Radix Angelicae Sinensis 20 parts and 10 parts, Radix Glycyrrhizae by weight.
The preparation method of dissolved granule as used in the description.
Embodiment 3:
In the present embodiment, the composition of U.S. newborn medicine, counts: the Radix Astragali 42 parts, Radix Ginseng Rubra 19 parts, the Radix Aucklandiae 5.5 parts, 31.5 parts, Fructus Jujubae, Medulla Tetrapanacis 9.5 parts, Semen Vaccariae (stir-fry) 28.5 parts, Squama Manis (cannon) 16 parts, Radix Bupleuri 9.5 parts, the Radix Paeoniae Alba 19 parts, the Rhizoma Atractylodis Macrocephalae (stir-fry) 19 parts, Radix Angelicae Sinensis 21 parts and 9.5 parts, Radix Glycyrrhizae by weight.
The preparation method of dissolved granule as used in the description.
In order to verify the actual effect of medicine of the present invention, the puerpera 240 routine inventors being participated in person to clinical treatment has done clinical trial.
Therapeutic effect formulates clinical observation according to " tcm syndrome standard ":
QI and blood deficiency: puerperal, breast was few, very less or completely without, milk is rare clearly, without swollen sense.Companion's lustreless complexion, mental fatigue with loss of appetite.Light red tongue, few tongue, deficient and thready pulse.
Stagnation of QI due to depression of the liver: puerperal, breast was few, very less or completely without, distending pain of the breast or slight fever.The breast side of body is unhappy.Irritated at heart, diet reduces, tongue fur BOHUANG, stringy pulse.
Use following methods to evaluate the size of breast in the present invention:
Udder size=bust size-under bust girth size
Wherein, the computational methods of " bust size " are, with BP point (i.e. breast point bustpoint) for measuring point, with the most plentiful place of moccasin chi horizontal survey chest one week, are bust size;
The computational methods of " under bust girth size " are, with bottom moccasin chi horizontal survey breast one week, are under bust girth size,
Concrete measuring position, can with reference to accompanying drawing 1.
According to above-mentioned diagnostic criteria and computational methods, 240 above-mentioned puerperas, at antenatal " udder size ", all between 10cm-12.5cm, but puerperal is all diagnosed as, suffer from the symptomes complice of QI and blood deficiency and stagnation of QI due to depression of the liver, occurred that postpartum mammary gland is flat, mammary gland is sagging, mammary gland is crooked, the problem of mammary gland atrophy to some extent.Calculate according to above standard, these 240 puerperas are in puerperal, and " udder size " all drops to 7.5cm-10cm.
240 puerperas are divided into 4 groups at random, are respectively A group, B group, C group, D group, often organize 60 people,
A, B, C these 3 groups takes respectively, U.S.'s breast drug particles electuary in the embodiment of the present invention 1,2,3, and starting to take in 3 days puerperal, one day 3 times, a 10g, 7 days is a course for the treatment of; D group as a control group, accepts routine obstetric Primary Care.
Take the puerpera of drug particles electuary of the present invention, after having taken a course for the treatment of, the symptom of deficient qi and blood and stagnation of QI due to depression of the liver has faded away, and tongue fur and pulse condition recover normal, and complexion is improved, and appetite increases.
By the computational methods of above-mentioned " udder size ", " udder size " taken after 3 courses for the treatment of carrys out Estimating curative effect, concrete as described in table 1-4:
Show the curative effect statistics after U.S.'s breast medicine dissolved granule of 60 routine maternity clothing embodiments 1 in 1A group
| Udder size (cm) | 7.5-10 | 10-12.5 | 12.5-15 | More than 15 |
| Number | 5 | 30 | 24 | 1 |
Show the curative effect statistics after U.S.'s breast medicine dissolved granule of 60 routine maternity clothing embodiments 2 in 2B group
| Udder size (cm) | 7.5-10 | 10-12.5 | 12.5-15 | More than 15 |
| Number | 2 | 27 | 29 | 2 |
Show the curative effect statistics after U.S.'s breast medicine dissolved granule of 60 routine maternity clothing embodiments 3 in 3C group
| udder size (cm) | 7.5-10 | 10-12.5 | 12.5-15 | more than 15 |
| number | 3 | 3. | 26 | 1 |
Curative effect after 60 routine puerperas accept routine obstetric Primary Care in table 4D group is added up
| Udder size (cm) | 7.5-10 | 10-12.5 | 12.5-15 | More than 15 |
| Number | 39 | 18 | 3 | 0 |
For 180 puerperas taking the U.S. newborn medicine of the present invention, after taking 3-7 days, puerpera's QI and blood is sufficient, and breast fills, and produces swelling sense.From the data of table 1-table 3, can find out, the present invention is U.S., and newborn medicine not only makes recovery of parturient arrive the size of antenatal udder size, and serves the effect of good breast enlargement, U.S. breast.
Its drug mechanism promotes that the second time hypertrophy of mammary glandular cell is grown, and make mammary gland recover elasticity, puerpera coordinates excellent medicated bra to hold up mammary gland puerperal again, substantially correct for the series of problems such as mammary gland is flat, mammary gland is sagging, mammary gland is crooked, mammary gland atrophy.Add continual galactopoiesis, while lactogenic, until after ablactation, all the time correct for the variation problem of breast shape, even if after ablactation, take above-mentioned 180 puerperas of the U.S. newborn medicine of the present invention, still keep mammary gland elasticity constant, take above-mentioned 180 puerperas of the U.S. newborn medicine of the present invention, not yet find corpus mamma hypertrophy and breast cancer case.
Claims (5)
1. a comprehensive breast beauty medicament, is characterized in that: the composition of described U.S.'s breast medicine, counts by weight
The Radix Astragali 38 ~ 42 parts, Radix Ginseng Rubra 19 ~ 21 parts, the Radix Aucklandiae 4.5 ~ 5.5 parts, 28.5 ~ 31.5 parts, Fructus Jujubae, Medulla Tetrapanacis 9.5 ~ 10.5 parts, Semen Vaccariae (stir-fry) 28.5 ~ 31.5 parts, Squama Manis (cannon) 14 ~ 16 parts, Radix Bupleuri 9.5 ~ 10.5 parts, the Radix Paeoniae Alba 19 ~ 21 parts, the Rhizoma Atractylodis Macrocephalae (stir-fry) 19 ~ 21 parts, Radix Angelicae Sinensis 19 ~ 21 parts and 9.5 ~ 10.5 parts, Radix Glycyrrhizae.
2. U.S. newborn medicine as claimed in claim 1, is characterized in that: the composition of described U.S.'s breast medicine, counts by weight
The Radix Astragali 40 parts, Radix Ginseng Rubra 20 parts, the Radix Aucklandiae 5 parts, 30 parts, Fructus Jujubae, Medulla Tetrapanacis 10 parts, Semen Vaccariae (stir-fry) 30 parts, Squama Manis (cannon) 15 parts, Radix Bupleuri 10 parts, the Radix Paeoniae Alba 20 parts, the Rhizoma Atractylodis Macrocephalae (stir-fry) 20 parts, Radix Angelicae Sinensis 20 parts and 10 parts, Radix Glycyrrhizae.
3. U.S. newborn medicine as claimed in claim 1, is characterized in that: described U.S.'s breast medicine is said solid preparation on pharmaceutics.
4. U.S. newborn medicine as claimed in claim 3, is characterized in that: described U.S.'s breast medicine is dissolved granule.
5. the preparation method of U.S.'s breast medicine as described in any one of Claims 1-4, is characterized in that: said method comprising the steps of:
(1) preparation of raw material: take the raw material Radix Astragali, Radix Ginseng Rubra, the Radix Aucklandiae, Fructus Jujubae, Medulla Tetrapanacis, Semen Vaccariae (stir-fry), Squama Manis (cannon), Radix Bupleuri, the Radix Paeoniae Alba, the Rhizoma Atractylodis Macrocephalae (stir-fry), Radix Angelicae Sinensis and Radix Glycyrrhizae by weight, put into extractor to be uniformly mixed, add the water soaking 30 minutes of 5-20 times amount;
(2) high-temp extracting and filtration: the raw material prepared in heating decoction step (1) 2-3 hours, leaching decocting liquid, its slag adds the water of 5-10 times amount again, heating decoction 1.5-2 hours, leaching decocting liquid, add the water of 4-6 times amount again toward its slag, heating decoction 1-1.5 hours, merges these three gained filtrates after filtering;
(3) heating is concentrated: by the filtrate of last for step (2) gained, heating is concentrated into paste, makes moisture be down to 28-31%;
(4) make soft material: by the thick paste of step (3) gained, add the starch of 2.5-3.5 times of volumes, stir, and then add the ethanol that volume ratio accounts for 70-90%, stir into uniform soft material;
(5) granulating is dry: soft material step (4) obtained, and makes granule through 12 mesh sieves, then by gained granule in 60-90 DEG C of Uniform Ventilation dryings;
(6) granule is screened: by the granule of step (5) gained; through 12 mesh sieve screenings; after suitably pulverizing without the granule of sieve; again again through 12 mesh sieve screenings; after being gathered by granule under twice screening, then sieve the fine powder gone wherein with 40 mesh sieves, obtain finished product electuary granule; not by the granule of 12 mesh sieves and the production that be can be used for next batch by the dust of 40 mesh sieves, be used for regulating the humidity of soft material.
(7) pack: by quantitative electuary granule being packed of often wrapping.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310232737.1A CN103356765B (en) | 2013-06-09 | 2013-06-09 | Comprehensive breast beauty medicament and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310232737.1A CN103356765B (en) | 2013-06-09 | 2013-06-09 | Comprehensive breast beauty medicament and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103356765A CN103356765A (en) | 2013-10-23 |
| CN103356765B true CN103356765B (en) | 2015-01-07 |
Family
ID=49359567
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310232737.1A Active CN103356765B (en) | 2013-06-09 | 2013-06-09 | Comprehensive breast beauty medicament and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103356765B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103690778B (en) * | 2013-12-27 | 2017-11-28 | 常州渝继医药科技有限公司 | A kind of comprehensive breast beauty external used medicine and preparation method thereof |
| CN104740174A (en) * | 2013-12-27 | 2015-07-01 | 常州渝继医药科技有限公司 | Drug for comprehensive conditioning of puerpera and preparation method thereof |
| CN107982175A (en) * | 2015-07-01 | 2018-05-04 | 王丹 | A kind of chest enlarge oil and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101695524A (en) * | 2009-10-23 | 2010-04-21 | 王继 | Galactopoietic medicament and preparation method thereof |
| CN101695523A (en) * | 2009-10-23 | 2010-04-21 | 王继 | Lactation qi and blood tonifying medicament and preparation method thereof |
| CN102579907A (en) * | 2012-03-18 | 2012-07-18 | 闫秋菊 | Lactation promoting soup |
-
2013
- 2013-06-09 CN CN201310232737.1A patent/CN103356765B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101695524A (en) * | 2009-10-23 | 2010-04-21 | 王继 | Galactopoietic medicament and preparation method thereof |
| CN101695523A (en) * | 2009-10-23 | 2010-04-21 | 王继 | Lactation qi and blood tonifying medicament and preparation method thereof |
| CN102579907A (en) * | 2012-03-18 | 2012-07-18 | 闫秋菊 | Lactation promoting soup |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103356765A (en) | 2013-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102763781B (en) | Nutrient for improving productivity of nursing sows and preparation method thereof | |
| CN103039668B (en) | Pueraria breast enlargement tea and preparation method thereof | |
| CN103356765B (en) | Comprehensive breast beauty medicament and preparation method thereof | |
| CN104666767A (en) | Composition for enhancing breasts and beautifying face as well as preparation method and application thereof | |
| CN103316205A (en) | Traditional Chinese medicine for treating iron-deficiency anemia and preparation method thereof | |
| CN101695523B (en) | Lactation qi and blood tonifying medicament and preparation method thereof | |
| CN103349690B (en) | Comprehensive lactation-promotion medicine and preparation method thereof | |
| CN104524292A (en) | Application of traditional Chinese medicine preparation in preparation of medicament for treating obesity | |
| CN103704698B (en) | A kind of lactation-promoting health-care food granules and preparation method thereof | |
| CN104740004A (en) | A synthetically-recuperating oral liquid for puerperae and a preparing method thereof | |
| CN101934046B (en) | Semifluid extract of deer foetus and preparation method thereof | |
| CN103690777A (en) | Oral liquid for postpartum uterus recovery and preparation method thereof | |
| CN104382029B (en) | Improve carp congee and the preparation method of women's alactation in postpartum | |
| CN103690630A (en) | Lactagogue suitable for relatively thin puerperal and preparation method of lactagogue | |
| CN103690778B (en) | A kind of comprehensive breast beauty external used medicine and preparation method thereof | |
| CN106309980B (en) | A kind of tocolytic agent and preparation method thereof | |
| CN104623268A (en) | Traditional Chinese medicine composition for treating and preventing postpartum hypogalactia of women | |
| CN107349262A (en) | A kind of breast beautifying medicine composition and preparation method thereof | |
| CN104740174A (en) | Drug for comprehensive conditioning of puerpera and preparation method thereof | |
| CN102872329B (en) | Traditional Chinese medicine granule for treating spleen-stomach deficiency type children's nutritional anemia | |
| CN105381330A (en) | Method for preparing health care food for diabetic patients | |
| CN104027699A (en) | Traditional Chinese medicine (TCM) for treating distending pain of breasts during menstruation induced by symptom of deficiency of liver and kidney | |
| CN103751514A (en) | Breast beautifying medicine for underweight parturient and preparation method thereof | |
| CN106689750A (en) | Premixed feed for promoting delivery of pregnant sow and preparation method thereof | |
| CN104740005A (en) | A synthetically-recuperating microcapsule for puerperae and a preparing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20171121 Address after: 404000 Chongqing Wanzhou Jing Kai District Peak Garden (Wanzhou Jing Kai District) Patentee after: Chongqing thick Czech Pharmaceutical Co., Ltd. Address before: Room 220, building No. 2, No. 151, Renmin Zhong Road, Hutang Town, Wujin District, Changzhou, Jiangsu Patentee before: Changzhou Yuji Medical Technology Co., Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190605 Address after: No. 188 Jingkai Avenue, Wanzhou District, Chongqing City, 404000 Patentee after: Chongqing Houjie Pharmaceutical Group Co., Ltd. Address before: 404000 Chongqing Wanzhou Jing Kai District Peak Garden (Wanzhou Jing Kai District) Patentee before: Chongqing thick Czech Pharmaceutical Co., Ltd. |